The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Rapid Response Innovation Awards, 2014Improving Gait in Parkinson’s Disease Patients by Non-invasive Electrical Stimulation of the Cerebellum
Study Rationale:
People with Parkinson’s disease (PD) can experience difficulties walking (e.g., freezing), which can lead to falls and negatively impact quality of life. These symptoms are difficult... -
Improved Neuromodulation Approaches, 2014Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson’s Disease
Study Rationale:
Currently deep brain stimulation (DBS) is limited to “open-loop” stimulation, without real-time adjustment to the patient’s state of activity, fluctuations and types of motor symptoms... -
Rapid Response Innovation Awards, 2014Creating Dopaminergic Neurons in the Adult Brain
Study Rationale:
Loss of dopaminergic neurons is seen in Parkinson’s disease, and transplantation of these neurons can greatly ease symptoms. However, several major drawbacks are associated with... -
Rapid Response Innovation Awards, 2014Effect of Dietary Ketosis On Alpha-Synuclein Accumulation
Study Rationale:
A key feature of Parkinson’s disease is abnormal accumulation of the protein alpha-synuclein. Production of organic compounds called ketones is a normal metabolic process that occurs... -
Rapid Response Innovation Awards, 2014D-512: a Novel, Multifunctional D2/D3 Receptor Agonist for the Treatment of Parkinson’s Disease
Study Rationale:
New drugs for the treatment of Parkinson’s disease (PD) that reduce symptoms and protect remaining neurons are desperately needed. This work examines a novel... -
Rapid Response Innovation Awards, 2014Levodopa Versus Dopamine Agonist after Deep Brain Stimulation in Parkinson's Disease
Study Rationale:
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established treatment for patients with advanced Parkinson's disease (PD). STN DBS improves motor...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.